SaphenionScience – 88 months veinglue

SaphenionScience – 88 months veinglue in 1335 cases

SaphenionScience – 88 months veinglue: Treatment with Cyanoacrylate glue is using for a long time. Since 1949 the chemical compound is known, first being used in operative medicine in the early 60s as a Tissue adhesive or replacement of wound sutures.

SaphenionScience: 88 months veinglue: Nearly all operative disciplines are using cyanoacrylate i.e dermatology, ophthalmology, orthopedics, surgery, orthodontics, interventional radiologists, vascular surgery. The risk of allergic reaction is not real – we have found one report in pubmed about an allergic reaction after therapy with cyanoacrylate vein glue, but we have not seen ourself an allergic reaction all over the time of 88 months.

The CE approval for sealing veins was in 9/2011 for Europe, the FDA approval in the US followed in 2/2015. The FDA states in its documentation: VenaSeal® is bio-compatibel and bioresorptive, non-carcinogenic and non-allergenic!

In the guidelines of the German Society of Phlebology (vein medicine), the vein glue has now been included in the treatment recommendations, in the United States, the VenaSeal has been declared a compulsory insurance.

SaphenionScience – 88 months veinglue in 1335 cases

Until November 4th. 2019 we sealed GSV in 1713 cases, SSV in 642 cases, VSAL in 92 cases, VSAM in 66 cases, Femoropopliteal vein in 18 cases, Giacomini`s vein in 2 cases. 

Treatment of one truncal vein in 385 cases, 746 patients received treatment for two truncal veins simultaneously, in 164 cases we treated three truncal veins. In 35 cases patients have got treatment of four truncal veins, in 4 case 5 truncal veins. One patient was treated for 6 truncal veins and an aneurysma in a single session (summary: 1335 patients). In 16 cases we treated truncal veins with ulcera crures: they healed 2 to 12 weeks after. We also treated patients with HIV, hepatitis or Parkinson without any pathological reaction or side effects.

Nearly all procedures carried out under sedation (dormicum i.v.), 170 patients without anesthesia (12,7%), one patient performed pain acupuncture in itself.

Nearly all patients choose music during op and left without compression stockings. We recommend compression stockings with a vein diameter up 1.2 cm. A 12 – chamber compression therapy immediately post op received 30% of patients.

The age of patients was between 17 – 92 y.

SaphenionScience – 88 months veinglue on 2532 truncal varicose veins: Our results

Duplex control follow up over 88 months: the first day 2532 veins were re-examined. 2520 veins were sealed initially   = 99,53% closure rate.

After 14 – 30 days we found 50 partial and 14 completely recanalized veins able to follow up of 2522 sealed truncal veins (99,60%) = 97,47% closure rate.

Three to four months post operationem we had 53 partial and 22 complete recanalisations able to follow up 1941 veins (76,5 %) = 97,07% closure rate.

After eight to ten months we observed 62 partial and 37 complete recanalisations able to follow up 1650 veins (65,1%) = 96,09% closure rate.

No further recanalisations were found after 88 months up to now! The closure rate over all the time of 87 months = 96,09%.      

Dieses Bild hat ein leeres Alt-Attribut. Der Dateiname ist Saphenion-Chart-VenaSeal-88-Monate-1024x632.jpg

SaphenionScience – 88 months veinglue: technique and side effects.

For the treatment of one truncal vein we need 1.2 ml to 1.8 ml of glue. The time of treatment for one GSV by experienced specialists is 10 – 15 min., for two veins 25 – 30 min.

Unspecific inflammatory reaction of tissue in 190 veins (7,7% truncal veins – no phlebitis!). Bleeding for> 12h ex punctio in 22 cases (continued anticoagulatio perioperative). Lymph-fistula at the puncture site in 19 cases (0,75%).

Glue(?) pimpel with cutaneous perforation 10 – 12 months after sealing in 3 cases. Open this pimple with incision, made a histopathological examination. The pimpels were healed in 14 days.

There was not to be found: sensory or motor nerv damages, no hyp-/ paresthesia, no permanent skin reaction, no phlebitis or thrombosis, no embolism.

SaphenionScience – 88 months veinglue: Our experiences and discussion

VenaSeal is one of the endovenous techniques with a high standard of effectiveness – quality standards are the same like other procedures. The cyanoacrylate vein glue (VenaSeal) has been included in the guidelines of the German Society of Phlebology (DGP) and is recommended.

VenaSeal treatment of all truncal veins, side branches and perforator veins until a diameter of 1,5 – 2 cm is real. Higher diameters are possible! We now don`t see advantages in thermal therapy options.

We also recommend vein glue for ectatic veins (over 1.5 cm in diameter), aneurysms, and postphlebitic truncal varicose veins. Separate punctures with special wing cannulas are also possible here to effectively close the aneurysm sac.

VenaSeal is first choice in treatment of truncal veins of the lower leg and truncal veins of GSV 3 – 4°.  VenaSeal is the expensive of all endovenous techniques, thats why therapy of more than one truncal vein simultaneously is recommendable. We can treat in normal 3 – 4 truncal veins with one catheter – Six truncal varicose veins were also closed simultaneously in one session, depending on the severity and anatomy. Here it is quite clear that the thermal systems (Laser, Radiowave, Microwave, are more likely to be used simultaneously with a maximum of 1 – 2 truncal veins. SONOVEIN is actual to be used for one truncal vein.

Closure rate of VenaSeal® compared to radiowave / Laser is same or better. VenaSeal® works without mechanical or thermal energy, side effects of laser or radio wave are not an issue here. We have no long-term radio wave or laser long-term studies that extend beyond 5 years. The sealing of varicose veins over 1.5 cm in diameter is also effective.

The painscore of sealing veins is significantly lower (1.3 VenaSeal – 3.4 radio frequency) than in radiofrequency or laser therapy. It remains to be seen to what extent the new thermal procedure SONOVEIN Echotherapy shows the same results.

Neither general anesthesia nor tumescence is required, as a rule postoperative compression therapy is not necessary either. This is – in the moment – not possible with the thermal system Laser, Radiowave or SONOVEIN Echotherapy (self test).

Dieses Bild hat ein leeres Alt-Attribut. Der Dateiname ist VenaSeal®-vs.-Radio-Frequency-7-years-1024x632.jpg
VenaSeal vs. radio wave: Own results over 7 years.

SaphenionSience – 88 months veinglue: Our resumes  

After 18 years of working with endovenous techniques, the conclusion: Our experience with the endovenous therapy and especially with the adhesive VenaSeal® make it our basic therapy for truncal varicose veins. Radical surgical therapy is only necessary for rare exceptional situations. In this respect, different statements of experts, colleagues, and health insurance companies are urgently critical to question after a long time of use (8 years). Thermal catheter therapy is not out, but the endovenous pathway has become more sophisticated! Noninvasive SONOVEIN Echotherapy is also a thermal procedure with the associated side effects but does not require catheters or vascular puncture. However, thrombosis prophylaxis and tumescent anesthesia is also indicated along the vein to be treated during the SONOVEIN therapy.

In addition to the venaseal treatment of varicose veins, we will continue to use a – currently considerably modernized RFITT radio wave system (veins, baker cysts).

The targeted introduction of the SONOVEIN system is currently deferred for clinical and commercial reasons. The indications for SONOVEIN and its advantages over the VenaSeal or the available minimally invasive thermal catheter procedures must first be precisely defined by the physicians.

Photos / Videos

Claudia Reuter, Utzius, Kunsthalle Rostock

Papers / Links:

Gibson et al.: Twenty-four-month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins.

Ivanova, Patricija: Post procedere neuropathy: comparison of surgery, EVLA and glue; Presentation on 2nd. NEEF, Riga, 17th.August 2019. 

Lawson J, S Gauw, C van Vlijmen, P Pronk, M Gaastra, M Mooij, C Wittens: Sapheon: the solution? Phlebology 2013;0:1-8

Morrison, Nick, and Kathleen Gibson: Veclose Study: Preliminary Month 1 Data; 2nd Annual Cyanoacrylate Embolization Symposium, Mainz, Jan. 18, 2014

Proebstle TM, Alm J,  Rasmussen L, Dimitri S, LawsonJA,  WhiteleyM,, Franklin IJ,  Davies AH: The European Multicenter Study On Cyanoacrylate Embolization Of Refluxing Great Saphenous Veins Without Tumescent Anaesthesia And Without Compression Therapy. eScope – study; Abstract presented  to the American Venous Forum  Annual Meeting 2013, Phoenix ( AZ) the  USA

Rasmussen LH, Bjoern L, Lawaetz M, Lawaetz B, Blemings A, Eklof B.:  Randomised clinical trial comparing endovenous laser ablation withthe  stripping of the great Saphenous vein: clinical outcome and recurrence after 2years. Eur J Vasc Endovasc Surg 2010;39:630 – 35

Thum, J: Single Center Erfahrungen aus 234 Stammvenenbehandlungen mit viskösem n – Butyl – 2 – Cyanoacrylat- Verwendbarkeit, Akzeptanz, Ergebnisse; vasomed 1, 2019; 28 – 31

Üdris, Ints: 6 years single center results „Baltic Vein Clinic“ of truncal varicose vein sealing; Presentation on 2nd. NEEF, Riga, 17th. August 2019.

Zierau U Th.: Venenverklebung versus Radiofrequenztherapie bei Varicosis – Verlaufsstudie über 36 Monate mit 1139 Behandlungen. vasomed 28 (2016) 212 – 216. 

Zierau U Th.: http://www.saphenion.de/news/konsensus-1-neef-endovenoese-krampfadertherapie.

http://vascular-endovascular-therapy.imedpub.com/venaseal-in-varicose-veinshistopathological-changes-of-tissue-and-veins.pdf

Jones AD, Boyle EM, Woltjer R, Jundt JP, Williams AN. Persistent type IV hypersensitivity after cyanoacrylate closure of the great saphenous vein. J Vasc Surg Cases Innov Tech. 2019 Aug 7;5(3):372-374. doi: 10.1016/j.jvscit.2019.05.004. eCollection 2019 Sep. PubMed PMID: 31440717; PubMed Central PMCID: PMC6699189

Navarro-Triviño FJ, Cuenca-Manteca J, Ruiz-Villaverde R. Allergic contact dermatitis with systemic symptoms caused by VenaSeal. Contact Dermatitis. 2019 Oct 31. doi: 10.1111/cod.13431. [Epub ahead of print] PubMed PMID: 31674037.

Almeida JI, Murray SP, Romero ME. Saphenous vein histopathology 5.5 years after cyanoacrylate closure. J Vasc Surg Venous Lymphat Disord. 2019 Jul 4. pii: S2213-333X(19)30325-7. doi: 10.1016/j.jvsv.2019.04.014. [Epub ahead of print] PubMed PMID: 31281102.

Park I, Kim D. Correlation Between the Immediate Remnant Stump Length and Vein Diameter After Cyanoacrylate Closure Using the VenaSeal System During Treatment of an Incompetent Great Saphenous Vein. Vasc Endovascular Surg. 2019 Oct 3:1538574419879563. doi:10.1177/1538574419879563. 
[Epub ahead of print] PubMed PMID: 31581906.

http://evtoday.com/2017/04/three-year-veclose-data-and-1-year-waves-data-presented-for-medtronics-venaseal-closure-system

http://www.saphenion.de/news/sealing-lower-leg-truncal-veins-kleben-von-stammkrampfadern-am-unterschenkel/J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):606-613.

http://www.ncbi.nlm.nih.gov/pubmed/?term=veclose

http://www.ncbi.nlm.nih.gov/pubmed/27052039

http://www.ncbi.nlm.nih.gov/pubmed/23482526

https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?query=venaseal&v%3Aproject=nlm-main-website

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=4841327

Hinterlasse einen Kommentar